Division of General Internal Medicine and Health Services Research, 1100 Glendon Ave., Suite 850-Room 858, Los Angeles, CA 90024, USA.
Obstet Gynecol Clin North Am. 2019 Sep;46(3):541-552. doi: 10.1016/j.ogc.2019.04.011.
Osteoporosis is a common condition among postmenopausal women. Women 65 years and older should receive bone mineral testing; younger women should undergo risk assessment using a formal risk assessment tool to determine if they should receive bone density testing. Many pharmacologic agents are available to treat women with osteoporosis on bone density testing. Women with previous hip or vertebral fractures should also receive osteoporosis pharmacotherapy.
骨质疏松症是绝经后妇女的常见病。65 岁及以上的女性应接受骨矿物质检测；较年轻的女性应使用正式的风险评估工具进行风险评估，以确定是否应进行骨密度测试。有许多药物可用于治疗经骨密度测试诊断为骨质疏松症的女性。有既往髋部或椎体骨折的女性也应接受骨质疏松症药物治疗。
